360 related articles for article (PubMed ID: 9498747)
41. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
42. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
[TBL] [Abstract][Full Text] [Related]
43. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
44. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
Torres BA; Griggs ND; Johnson HM
Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
[TBL] [Abstract][Full Text] [Related]
45. The J beta segment of the T cell receptor contributes to the V beta-specific T cell expansion caused by staphylococcal enterotoxin B and Urtica dioica superantigens.
Musette P; Galelli A; Truffa-Bachi P; Peumans W; Kourilsky P; Gachelin G
Eur J Immunol; 1996 Mar; 26(3):618-22. PubMed ID: 8605929
[TBL] [Abstract][Full Text] [Related]
46. The CD8 T cell response to staphylococcal enterotoxins.
Herrmann T; MacDonald HR
Semin Immunol; 1993 Feb; 5(1):33-9. PubMed ID: 8467093
[TBL] [Abstract][Full Text] [Related]
47. Mutational analysis and molecular modeling of the binding of Staphylococcus aureus enterotoxin C2 to a murine T cell receptor Vbeta10 chain.
Rössle SC; Bisch PM; Lone YC; Abastado JP; Kourilsky P; Bellio M
Eur J Immunol; 2002 Aug; 32(8):2172-8. PubMed ID: 12209629
[TBL] [Abstract][Full Text] [Related]
48. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
[TBL] [Abstract][Full Text] [Related]
49. Staphylococcal enterotoxin A induces survival of VH3-expressing human B cells by binding to the VH region with low affinity.
Domiati-Saad R; Lipsky PE
J Immunol; 1998 Aug; 161(3):1257-66. PubMed ID: 9686586
[TBL] [Abstract][Full Text] [Related]
50. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype.
Mollick JA; Chintagumpala M; Cook RG; Rich RR
J Immunol; 1991 Jan; 146(2):463-8. PubMed ID: 1987273
[TBL] [Abstract][Full Text] [Related]
51. Staphylococcal toxins bind to different sites on HLA-DR.
Chintagumpala MM; Mollick JA; Rich RR
J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
[TBL] [Abstract][Full Text] [Related]
52. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
[TBL] [Abstract][Full Text] [Related]
53. Superantigen-mediated deletion of specific T cell receptor V beta subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1.
Komanduri KV; Salha MD; Sékaly RP; McCune JM
J Immunol; 1997 Jan; 158(2):544-9. PubMed ID: 8992966
[TBL] [Abstract][Full Text] [Related]
54. A structural and functional comparison of staphylococcal enterotoxins A and C2 reveals remarkable similarity and dissimilarity.
Schad EM; Papageorgiou AC; Svensson LA; Acharya KR
J Mol Biol; 1997 Jun; 269(2):270-80. PubMed ID: 9191070
[TBL] [Abstract][Full Text] [Related]
55. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.
Hedlund G; Dohlsten M; Herrmann T; Buell G; Lando PA; Segrén S; Schrimsher J; MacDonald HR; Sjögren HO; Kalland T
J Immunol; 1991 Dec; 147(12):4082-5. PubMed ID: 1753087
[TBL] [Abstract][Full Text] [Related]
56. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
57. Separation of function between the domains of toxic shock syndrome toxin-1.
Wahlsten JL; Ramakrishnan S
J Immunol; 1998 Jan; 160(2):854-9. PubMed ID: 9551921
[TBL] [Abstract][Full Text] [Related]
58. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
Brouillard JN; Günther S; Varma AK; Gryski I; Herfst CA; Rahman AK; Leung DY; Schlievert PM; Madrenas J; Sundberg EJ; McCormick JK
J Mol Biol; 2007 Apr; 367(4):925-34. PubMed ID: 17303163
[TBL] [Abstract][Full Text] [Related]
59. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
Wang S; Li Y; Xiong H; Cao J
Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
[TBL] [Abstract][Full Text] [Related]
60. Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins.
Buelow R; O'Hehir RE; Schreifels R; Kummerehl TJ; Riley G; Lamb JR
J Immunol; 1992 Jan; 148(1):1-6. PubMed ID: 1530792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
